Dong Liang

8.9k total citations · 2 hit papers
140 papers, 4.4k citations indexed

About

Dong Liang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dong Liang has authored 140 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 26 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Dong Liang's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Dong Liang is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Dong Liang collaborates with scholars based in United States, China and Canada. Dong Liang's co-authors include Chun Li, Min Zhou, Mei Tian, Wei Lü, Rui Zhang, Miao Huang, Marites P. Melancon, Xifeng Wu, Qian Huang and Shaoli Song and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Dong Liang

133 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Chelator-Free Multifunctional [⁶⁴Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy

2010 639 citations Dong Liang, Chun Li et al. profile →
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α

2012 369 citations Dong Liang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dong Liang United States	31	1.6k	1.4k	898	860	650	140	4.4k
Seung Young Lee South Korea	34	2.0k 1.3×	1.2k 0.9×	547 0.6×	1.2k 1.5×	826 1.3×	129	4.9k
Pengfei Rong China	39	1.5k 0.9×	2.6k 1.9×	1.4k 1.5×	769 0.9×	315 0.5×	163	5.3k
Yan Luo China	40	2.3k 1.4×	719 0.5×	825 0.9×	816 0.9×	523 0.8×	201	6.2k
Yiyao Liu China	42	2.0k 1.2×	2.3k 1.7×	1.1k 1.2×	1.3k 1.5×	539 0.8×	218	5.6k
Zhiyuan Hu China	40	2.6k 1.6×	1.8k 1.3×	1.2k 1.3×	876 1.0×	1.1k 1.7×	280	6.9k
Jianfeng Guo China	48	2.3k 1.4×	1.3k 1.0×	1.1k 1.2×	1.1k 1.3×	820 1.3×	179	6.8k
Yongyi Zeng China	40	2.4k 1.5×	2.4k 1.7×	1.5k 1.7×	617 0.7×	805 1.2×	222	6.2k
Tapani Viitala Finland	38	2.3k 1.4×	1.4k 1.0×	417 0.5×	838 1.0×	513 0.8×	116	4.6k
Baoan Chen China	41	2.8k 1.7×	1.7k 1.2×	1.2k 1.4×	1.3k 1.5×	1.1k 1.7×	195	5.7k
Fabio Corsi Italy	38	1.6k 1.0×	899 0.6×	428 0.5×	882 1.0×	509 0.8×	178	4.3k

Countries citing papers authored by Dong Liang

Since Specialization

Citations

This map shows the geographic impact of Dong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Liang more than expected).

Fields of papers citing papers by Dong Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Liang. The network helps show where Dong Liang may publish in the future.

Co-authorship network of co-authors of Dong Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Liang. A scholar is included among the top collaborators of Dong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Liang. Dong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dileep, K.V., Huan Xie, Dong Liang, et al.. (2025). The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 24(9). 1308–1319. 3 indexed citations

Meng, Qingqi, Yan Mi, Libin Xu, et al.. (2025). A quinolinyl analog of resveratrol improves neuronal damage after ischemic stroke by promoting Parkin-mediated mitophagy. Chinese Journal of Natural Medicines. 23(2). 214–224. 1 indexed citations

Xie, Huan, et al.. (2024). Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac. Molecules. 29(24). 5867–5867. 1 indexed citations

Xie, Huan, et al.. (2024). Species Differences in Ezetimibe Glucuronidation. Metabolites. 14(11). 569–569.

Sun, Rongjin, et al.. (2023). Development of a novel UPLC-MS/MS method for the simultaneous quantification of mycophenolic mofetil, mycophenolic acid, and its major metabolites: Application to pharmacokinetic and tissue distribution study in rats. Journal of Pharmaceutical and Biomedical Analysis. 234. 115504–115504. 3 indexed citations

Josiah, Sunday Solomon, Jing Zhou, Yanhui Zhang, et al.. (2023). The role of SLC12A family of cation-chloride cotransporters and drug discovery methodologies. Journal of Pharmaceutical Analysis. 13(12). 1471–1495. 12 indexed citations

Selvam, Chelliah, et al.. (2023). Development and application of LC-MS/MS method for the quantification of hydrogen sulfide in the eye. Analytical Biochemistry. 687. 115448–115448. 1 indexed citations

Pratap, Uday P., Michael Tidwell, Suryavathi Viswanadhapalli, et al.. (2023). Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma. Molecular Cancer Therapeutics. 22(11). 1248–1260. 4 indexed citations

Kwan, Suet‐Ying, Peng Wei, Michelle I. Savage, et al.. (2022). Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. Cancer Prevention Research. 16(1). 17–28. 5 indexed citations

10.

Du, Ting, et al.. (2022). Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS. Molecules. 27(9). 2854–2854. 7 indexed citations

11.

Wang, Jing, Jing Wang, Han Zhang, et al.. (2020). Gold nanobipyramid-loaded black phosphorus nanosheets for plasmon-enhanced photodynamic and photothermal therapy of deep-seated orthotopic lung tumors. Acta Biomaterialia. 107. 260–271. 46 indexed citations

12.

Wang, Dawei, Zhao Cheng, Meng Zhao, et al.. (2019). PTPN9 induces cell apoptosis by mitigating the activation of Stat3 and acts as a tumor suppressor in colorectal cancer. SHILAP Revista de lepidopterología. 2 indexed citations

13.

Liang, Dong. (2017). Study on building energy - saving performance of diatomite materials. SHILAP Revista de lepidopterología. 62. 535–540. 2 indexed citations

14.

Wen, Chi-Pang, Fanmao Zhang, Dong Liang, et al.. (2014). The Ability of Bilirubin in Identifying Smokers with Higher Risk of Lung Cancer: A Large Cohort Study in Conjunction with Global Metabolomic Profiling. Clinical Cancer Research. 21(1). 193–200. 50 indexed citations

15.

Liang, Dong, et al.. (2011). EFFECT OF AC CURRENT ON CORROSION POTENTIAL OF Q235 STEEL. Acta Metallurgica Sinica. 47(8). 997–1002. 10 indexed citations

16.

Liang, Dong. (2011). INVESTIGATION PROGRESS OF ALTERNATING CURRENT CORROSION ON BURIED PIPELINES. Zhongguo fushi yu fanghu xuebao. 31(3). 173–178. 2 indexed citations

17.

Liang, Dong, Larissa A. Meyer, David W. Chang, et al.. (2010). Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response. Cancer Research. 70(23). 9765–9776. 102 indexed citations

18.

Wen, Xiaoxia, Mi-Ae Lyu, Rui Zhang, et al.. (2010). Biodistribution, Pharmacokinetics, and Nuclear Imaging Studies of 111In-labeled rGel/BLyS Fusion Toxin in SCID Mice Bearing B Cell Lymphoma. Molecular Imaging and Biology. 13(4). 721–729. 9 indexed citations

19.

Liang, Dong. (2006). Preparation and characters of chitosan-g-salicylic acid. Zhongguo yaoke daxue xuebao. 1 indexed citations

20.

Wen, Xiaoxia, Ke Shi, Sidney Wallace, et al.. (2003). Improved Radiolabeling of PEGylated Protein: PEGylated Annexin V for Noninvasive Imaging of Tumor Apoptosis. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 819–827. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact